Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2005
02/09/2005EP0365597B2 Improved processes for the treatment of vascular disease
02/09/2005CN1578838A Method and means for producing protein with prospective post-translation modification
02/09/2005CN1578788A Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas
02/09/2005CN1578787A Vectors, constructs, and transgenic plants for hpv-11 and hpv-16 l1 capsid protein
02/09/2005CN1578785A Novel immunogenic compositions for the prevention and treatment of meningococcal disease
02/09/2005CN1578678A Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
02/09/2005CN1578672A Rsv基因表达疫苗 Rsv gene expression vaccine
02/09/2005CN1578671A Peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis
02/09/2005CN1576840A Methods for diagnosis and therapy of cancer and composition useful therein
02/09/2005CN1576369A Prawn leukasmus rhabdovirus dUTPase gene and coded polypeptide thereof
02/09/2005CN1576368A Prawn leukasmus rhabdovirus VP26 gene correlated with infection and coded polypeptide thereof
02/09/2005CN1576367A Prawn leukasmus rhabdovirus WP486 gene and coded polypeptide thereof
02/09/2005CN1576366A A hematopoietic cell specific cell cycle control gene and its coded protein
02/09/2005CN1575816A Compounds for the treatment of female sexual dysfunction
02/09/2005CN1188528C Intercellular adhesion molecule-3 and its binding ligands
02/09/2005CN1188522C Target thrombolytic protein expressing plasmid for thrombus and its construction
02/09/2005CN1188519C Fusion proteins comprising HIV-1 Tat and /or Nef proteins
02/09/2005CN1188427C Recombinant chimeric peptide antigen for detecting HCMV antibody and production method thereof
02/09/2005CN1188172C G-CSF conjugates
02/09/2005CN1188171C Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby
02/09/2005CN1188031C Corticotropin releasing factor receptor 2 deficient mice and uses thereof
02/08/2005US6853215 Programmable I/O element circuit for high speed logic devices
02/08/2005US6852910 Plant recombination proteins
02/08/2005US6852908 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production
02/08/2005US6852874 Second cycle asymmetric dihydroxylation reaction
02/08/2005US6852849 Non-oligomerizing tandem fluorescent proteins
02/08/2005US6852847 B7 nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins and inhibitors of such proteins or nucleic acid molecules
02/08/2005US6852846 Viral amplification of recombinant messenger RNA in transgenic plants
02/08/2005US6852844 Human protocadherin proteins and polynucleotides encoding the same
02/08/2005US6852841 Frozen food product
02/08/2005US6852840 Human kielin-like proteins and polynucleotides encoding the same
02/08/2005US6852839 Fhm, a novel member of the TNF ligand supergene family
02/08/2005US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
02/08/2005US6852837 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis
02/08/2005US6852836 Gene encoding brain-specific membrane protein
02/08/2005US6852835 DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses
02/08/2005US6852834 Fusion peptides isolatable by phase transition
02/08/2005US6852832 Single stranded DNA binding proteins from archaea
02/08/2005US6852818 Molecularly imprinted polymers produced by template polymerization
02/08/2005US6852703 A vector comprising a nucleotide sequence of interest ("NOI") encoding a product of interest ("POI") is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI
02/08/2005US6852700 Colostrinin, and uses thereof
02/08/2005US6852696 Inhibitors of glycosaminoglycans
02/08/2005US6852695 For therapy of hyperglycemic disorders
02/08/2005US6852691 Anti-angiogenic peptides and methods of use thereof
02/08/2005US6852685 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
02/08/2005US6852538 Response element (RE) for Nur family members
02/08/2005US6852529 Gloucose-regulated mRNA instability element
02/08/2005US6852528 Human and mouse uroplakin II gene transcriptional regulatory elements
02/08/2005US6852523 B.subtilis, wherein one or more genes involved in the biosynthesis of isovaleric acids have been modified such that the strain cannot produce substantial amounts of isovaleric acids; improved food flavors
02/08/2005US6852522 Methods and interferon deficient substrates for the propagation of viruses
02/08/2005US6852515 For heparan sulfate binding extracellular domain; proteoglycans; in-situ; tumors/wound healing
02/08/2005US6852513 Solid phase synthesis; catalysis without secondary reactions
02/08/2005US6852512 Expression vectors for production of foreign proteins as soluble forms
02/08/2005US6852511 Heat-inducible promoter
02/08/2005US6852510 Host cells containing multiple integrating vectors
02/08/2005US6852509 Anti-P53 single-chain antibody fragments and their uses
02/08/2005US6852508 Chemokine with amino-terminal modifications
02/08/2005US6852506 For neurological/vision/kidney/liver diagnosis/therapy; embryogenesis/angiogenesis activators; anticancer/tumor agents; wound healing agents
02/08/2005US6852498 Screening efficiency of microbiocides at preventing oomycete infections; obtain sample containing oomycetes, incubate with microbiocide, monitor oomycete response to microbiocide
02/08/2005US6852497 Fusion protein
02/08/2005US6852486 Detection of leukocyte antigen in sample; obtain cell sample, incubate with bindng protein, detect bound protein, presence of bound protein indicates leukocyte antigen presence
02/08/2005US6852482 For drug screening; Alzheimer's disease prophylaxis/therapy
02/08/2005US6852352 Soluble milk protein concentrate devoid of chemical precipitants: alpha-lactalbumin-enriched, beta-lactoglobulin and alpha-lactalbumin-enriched whey protein isolate (WPI), or sialyllactose-enriched WPI
02/08/2005US6852338 Isolation of blood and lymph from molluscs; obtain molluscs, remove blood and lymph, evaluate tissues
02/08/2005US6852324 Immunization for ebola virus infection
02/08/2005US6852322 Surface proteins of Leptospira
02/08/2005US6852321 Lectin-derived progenitor cell preservation factor and methods of use
02/08/2005US6852320 T cell inhibitory receptor compositions and uses thereof
02/08/2005US6852313 For treating blood disorders; cytokines/interleukins
02/08/2005CA2184183C Inhibin compositions and methods of use thereof
02/08/2005CA2180103C Gene encoding adseverin
02/08/2005CA2150928C Expression system for producing apolipoprotein ai-m
02/08/2005CA2116914C Novel plasmid for production of crm protein and diphtheria toxin
02/08/2005CA2110933C Kainate-binding, human cns receptors of the eaa3 family
02/08/2005CA2096408C Retroviral protease inhibitors
02/03/2005WO2005010205A2 Biomarkers fo aggrecanase activity
02/03/2005WO2005010197A2 A systemic small rna signaling system in plants
02/03/2005WO2005010190A1 Ssx-2 peptides presented by hla class ii molucules
02/03/2005WO2005010178A1 Process for preparing recombinant cell having high fibrinogen production capability and cell having high production capability
02/03/2005WO2005010174A2 Methods for use of an lkb1/strad7mo25 complex
02/03/2005WO2005010165A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
02/03/2005WO2005010163A2 Compositions and methods for immunotherapy of human immunotherapy of human immunodeficiency virus (hiv)
02/03/2005WO2005010157A2 Use of pleiotrophin in the diagnosis, treatment and prevention of disease
02/03/2005WO2005010152A2 Human mast cell-expressed membrane protein
02/03/2005WO2005010050A1 Hetero type pentamer recombinant vaccine
02/03/2005WO2005010047A2 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof
02/03/2005WO2005010046A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
02/03/2005WO2005010045A1 Compositions and methods relating to multimeric and oligomeric soluble fragments of the tweak receptor
02/03/2005WO2005010044A2 Il-17 a/f heterologous polypeptides and therapeutic uses thereof
02/03/2005WO2005010043A1 A method of improving efficacy of biological response-modifying proteins and the exemplary muteins
02/03/2005WO2005010042A1 7a5/prognostin and use thereof for the diagnostic and therapy of tumors
02/03/2005WO2005010041A2 Regulatory region for xenopus lef-1 expression and its use
02/03/2005WO2005010040A1 Eimeria tenella antigen for immunotherapy of coccidiosis
02/03/2005WO2005010039A1 Bsep polypeptide variants and uses thereof
02/03/2005WO2005010038A2 Peptide protein translation inhibitor and the use thereof for protein translation control
02/03/2005WO2005010037A1 Polypeptides, nucleic acids coding therefor, from the mold fungus cladosporium herbarum and the production and use thereof in diagnosis and therapy
02/03/2005WO2005010036A1 Vaccine and compositions for the prevention and treatment of neisserial infections
02/03/2005WO2005010035A2 Alternate reading frame polypeptides derived from hepatitis c and methods of their use
02/03/2005WO2005010034A1 Soluble fragments of the sars-cov spike glycoprotein
02/03/2005WO2005010033A1 New soluble and stabilized trimeric form of gp41 polypeptides